Biomarker testing in lung carcinoma cytology specimens: A perspective from members of the Pulmonary Pathology Society

Sinchita Roy-Chowdhuri, Dara L. Aisner, Timothy Craig Allen, Mary Beth Beasley, Alain Borczuk, Philip T. Cagle, Vera Capelozzi, Sanja Dacic, Gilda Da Cunha Santos, Lida P. Hariri, Keith M. Kerr, Sylvie Lantuejoul, Mari Mino-Kenudson, Andre Moreira, Kirtee Raparia, Natasha Rekhtman, Lynette Sholl, Eric Thunnissen, Ming Sound Tsao, Marina ViveroYasushi Yatabe

Research output: Contribution to journalReview article

54 Scopus citations

Abstract

The advent of targeted therapy in lung cancer has heralded a paradigm shift in the practice of cytopathology with the need for accurately subtyping lung carcinoma, as well as providing adequate material for molecular studies, to help guide clinical and therapeutic decisions. The variety and versatility of cytologic-specimen preparations offer significant advantages to molecular testing; however, they frequently remain underused. Therefore, evaluating the utility and adequacy of cytologic specimens is critical, not only from a lung cancer diagnosis standpoint but also for the myriad ancillary studies that are necessary to provide appropriate clinical management. A large fraction of lung cancers are diagnosed by aspiration or exfoliative cytology specimens, and thus, optimizing strategies to triage and best use the tissue for diagnosis and biomarker studies forms a critical component of lung cancer management. This review focuses on the opportunities and challenges of using cytologic specimens for molecular diagnosis of lung cancer and the role of cytopathology in the molecular era.

Original languageEnglish (US)
Pages (from-to)1267-1272
Number of pages6
JournalArchives of Pathology and Laboratory Medicine
Volume140
Issue number11
DOIs
StatePublished - Nov 1 2016

    Fingerprint

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medical Laboratory Technology

Cite this

Roy-Chowdhuri, S., Aisner, D. L., Allen, T. C., Beasley, M. B., Borczuk, A., Cagle, P. T., Capelozzi, V., Dacic, S., Da Cunha Santos, G., Hariri, L. P., Kerr, K. M., Lantuejoul, S., Mino-Kenudson, M., Moreira, A., Raparia, K., Rekhtman, N., Sholl, L., Thunnissen, E., Tsao, M. S., ... Yatabe, Y. (2016). Biomarker testing in lung carcinoma cytology specimens: A perspective from members of the Pulmonary Pathology Society. Archives of Pathology and Laboratory Medicine, 140(11), 1267-1272. https://doi.org/10.5858/arpa.2016-0091-SA